» Articles » PMID: 11133376

Longitudinal Assessment of Pseudomonas Aeruginosa in Young Children with Cystic Fibrosis

Overview
Journal J Infect Dis
Date 2001 Jan 3
PMID 11133376
Citations 221
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa lung infection is an important cause of morbidity and mortality in cystic fibrosis (CF). Longitudinal assessment of the phenotypic changes in P. aeruginosa isolated from young children with CF is lacking. This study investigated genotypic and phenotypic changes in P. aeruginosa from oropharynx (OP) and bronchoalveolar lavage fluid (BALF) in a cohort of 40 CF patients during the first 3 years of life; antibody response was also examined. A high degree of genotypic variability was identified, and each patient had unique genotypes. Early isolates had a phenotype distinct from those of usual CF isolates: generally nonmucoid and antibiotic susceptible. Genotype and phenotype correlated between OP and BALF isolates. As determined by culture, 72.5% of patients demonstrated P. aeruginosa during their first 3 years. On the basis of combined culture and serologic results, 97.5% of patients had evidence of infection by age 3 years, which suggests that P. aeruginosa infection occurs early in CF and may be intermittent or undetectable by culture.

Citing Articles

Genetic Concordance of Staphylococcus aureus From Oropharyngeal and Sputum Cultures in People With Cystic Fibrosis.

Zirbes C, Feder A, Pamatmat A, Bartels A, Pitcher N, Rozen A Pediatr Pulmonol. 2025; 60(1):e27475.

PMID: 39785222 PMC: 11715147. DOI: 10.1002/ppul.27475.


Novel broadly reactive monoclonal antibody protects against infection.

Mateu-Borras M, Dublin S, Kang J, Monroe H, Sen-Kilic E, Miller S Infect Immun. 2024; 93(1):e0033024.

PMID: 39670709 PMC: 11784295. DOI: 10.1128/iai.00330-24.


Quorum sensing regulation of Psl polysaccharide production by .

Carey J, Lamont S, Wozniak D, Dandekar A, Parsek M J Bacteriol. 2024; 206(12):e0031224.

PMID: 39530727 PMC: 11656772. DOI: 10.1128/jb.00312-24.


Tracing the path of Quorum sensing molecules in cystic fibrosis mucus in a biomimetic in vitro permeability platform.

Garbero O, Sardelli L, Butnarasu C, Frasca E, Medana C, Dal Bello F Sci Rep. 2024; 14(1):25907.

PMID: 39472521 PMC: 11522324. DOI: 10.1038/s41598-024-77375-w.


Mucus polymer concentration and adaptation converge to define the antibiotic response of during chronic lung infection.

Greenwald M, Meinig S, Plott L, Roca C, Higgs M, Vitko N mBio. 2024; 15(6):e0345123.

PMID: 38651896 PMC: 11237767. DOI: 10.1128/mbio.03451-23.